Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.

Surgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve...

Full description

Bibliographic Details
Main Authors: Claudia Spies, Alawi Luetz, Gunnar Lachmann, Markus Renius, Clarissa von Haefen, Klaus-Dieter Wernecke, Marcus Bahra, Alexander Schiemann, Marco Paupers, Christian Meisel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4671639?pdf=render
_version_ 1811286640086220800
author Claudia Spies
Alawi Luetz
Gunnar Lachmann
Markus Renius
Clarissa von Haefen
Klaus-Dieter Wernecke
Marcus Bahra
Alexander Schiemann
Marco Paupers
Christian Meisel
author_facet Claudia Spies
Alawi Luetz
Gunnar Lachmann
Markus Renius
Clarissa von Haefen
Klaus-Dieter Wernecke
Marcus Bahra
Alexander Schiemann
Marco Paupers
Christian Meisel
author_sort Claudia Spies
collection DOAJ
description Surgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity. This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation. Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time.In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] <10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 μg/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on monocytes was measured daily until day 5 after surgery. Infections and delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR on monocytes, and secondary outcomes were duration of infection and delirium.mHLA-DR was significantly increased compared to placebo (p < 0.001) and influenza vaccination (p < 0.001) on the second postoperative day. Compared with placebo, GM-CSF-treated patients revealed shorter duration of infection (p < 0.001); the duration of delirium was increased after vaccination (p = 0.003).Treatment with GM-CSF in patients with postoperative immune suppression was safe and effective in restoring monocytic immune competence. Furthermore, therapy with GM-CSF reduced duration of infection in immune compromised patients. However, influenza vaccination increased duration of delirium after major surgery.www.controlled-trials.com ISRCTN27114642.
first_indexed 2024-04-13T03:03:36Z
format Article
id doaj.art-d3e6ac27ce0743ed906224d934b9a532
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T03:03:36Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d3e6ac27ce0743ed906224d934b9a5322022-12-22T03:05:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014400310.1371/journal.pone.0144003Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.Claudia SpiesAlawi LuetzGunnar LachmannMarkus ReniusClarissa von HaefenKlaus-Dieter WerneckeMarcus BahraAlexander SchiemannMarco PaupersChristian MeiselSurgical patients are at high risk for developing infectious complications and postoperative delirium. Prolonged infections and delirium result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity. This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation. Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time.In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] <10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 μg/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on monocytes was measured daily until day 5 after surgery. Infections and delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR on monocytes, and secondary outcomes were duration of infection and delirium.mHLA-DR was significantly increased compared to placebo (p < 0.001) and influenza vaccination (p < 0.001) on the second postoperative day. Compared with placebo, GM-CSF-treated patients revealed shorter duration of infection (p < 0.001); the duration of delirium was increased after vaccination (p = 0.003).Treatment with GM-CSF in patients with postoperative immune suppression was safe and effective in restoring monocytic immune competence. Furthermore, therapy with GM-CSF reduced duration of infection in immune compromised patients. However, influenza vaccination increased duration of delirium after major surgery.www.controlled-trials.com ISRCTN27114642.http://europepmc.org/articles/PMC4671639?pdf=render
spellingShingle Claudia Spies
Alawi Luetz
Gunnar Lachmann
Markus Renius
Clarissa von Haefen
Klaus-Dieter Wernecke
Marcus Bahra
Alexander Schiemann
Marco Paupers
Christian Meisel
Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
PLoS ONE
title Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
title_full Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
title_fullStr Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
title_full_unstemmed Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
title_short Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.
title_sort influence of granulocyte macrophage colony stimulating factor or influenza vaccination on hla dr infection and delirium days in immunosuppressed surgical patients double blind randomised controlled trial
url http://europepmc.org/articles/PMC4671639?pdf=render
work_keys_str_mv AT claudiaspies influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT alawiluetz influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT gunnarlachmann influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT markusrenius influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT clarissavonhaefen influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT klausdieterwernecke influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT marcusbahra influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT alexanderschiemann influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT marcopaupers influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial
AT christianmeisel influenceofgranulocytemacrophagecolonystimulatingfactororinfluenzavaccinationonhladrinfectionanddeliriumdaysinimmunosuppressedsurgicalpatientsdoubleblindrandomisedcontrolledtrial